Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Hepatology ◽  
2015 ◽  
Vol 62 (1) ◽  
pp. 79-86 ◽  
Author(s):  
K. Rajender Reddy ◽  
Marc Bourlière ◽  
Mark Sulkowski ◽  
Masao Omata ◽  
Stefan Zeuzem ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Safety And Efficacy ◽  
Efficacy Analysis ◽  
Compensated Cirrhosis

scholarly journals Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

2017 ◽  
Vol 152 (6) ◽  
pp. 1372-1382.e2 ◽  
Author(s):  
Ira M. Jacobson ◽  
Eric Lawitz ◽  
Paul Y. Kwo ◽  
Christophe Hézode ◽  
Cheng-Yuan Peng ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Integrated Analysis ◽  
Hepatitis C Virus Infection ◽  
Safety And Efficacy ◽  
Compensated Cirrhosis

scholarly journals Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection

2022 ◽  
Vol 5 (1) ◽  
Author(s):  
Akio Miyasaka ◽  
Yuichi Yoshida ◽  
Akihiko Murakami ◽  
Takao Hoshino ◽  
Kei Sawara ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Japanese Patients ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document